Brevan Howard Capital Management LP Has $5.19 Million Holdings in Tenet Healthcare Corporation $THC

Brevan Howard Capital Management LP decreased its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 32.7% in the 3rd quarter, Holdings Channel reports. The fund owned 25,537 shares of the company’s stock after selling 12,406 shares during the period. Brevan Howard Capital Management LP’s holdings in Tenet Healthcare were worth $5,185,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Boston Partners increased its position in Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares in the last quarter. Ameriprise Financial Inc. grew its stake in shares of Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after buying an additional 157,109 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after buying an additional 720,160 shares in the last quarter. Norges Bank bought a new position in shares of Tenet Healthcare in the 2nd quarter valued at $206,981,000. Finally, Bank of America Corp DE grew its position in Tenet Healthcare by 9.6% during the 3rd quarter. Bank of America Corp DE now owns 1,078,585 shares of the company’s stock worth $218,996,000 after acquiring an additional 94,903 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on THC shares. Truist Financial raised their price objective on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Barclays upped their price target on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Mizuho increased their price objective on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Jefferies Financial Group upped their price target on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $250.56.

Insider Activity

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the completion of the transaction, the executive vice president owned 8,012 shares in the company, valued at approximately $1,875,128.48. The trade was a 74.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 46,517 shares of company stock worth $10,943,111 over the last three months. 0.81% of the stock is currently owned by insiders.

Tenet Healthcare Stock Up 1.4%

Shares of NYSE:THC opened at $227.79 on Monday. The firm has a market cap of $19.81 billion, a P/E ratio of 14.71, a PEG ratio of 1.10 and a beta of 1.39. Tenet Healthcare Corporation has a 52-week low of $109.82 and a 52-week high of $247.21. The business’s 50 day simple moving average is $213.46 and its two-hundred day simple moving average is $204.31. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same period in the prior year, the firm earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, research analysts forecast that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.